Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 201 entries
View as:

Effect of Dumbbell Exercise on Arteriovenous Fistula in Patients With Hemodialysis

Phase: N/A Priority: Normal
NCT ID: NCT03741985 Org: User:
Start: 11/10/18 End: 02/28/19 Due: 02/28/20

A Prospective Controlled Study of Serum suPAR in the CsA-treated FSGS Patients

Phase: N/A Priority: Normal
NCT ID: NCT01468493 Org: User:
Start: 01/31/11 End: 01/31/19 Due: 01/31/20

Navigated Repetitive Transcranial Magnetic Stimulation for Parkinson's Disease With Depression or Cognitive Impairment

Phase: N/A Priority: Normal
NCT ID: NCT04707378 Org: User:
Start: 12/30/20 End: 12/31/21 Due: 12/31/22

The PET-CT Predicting Response to Immunochemotherapy in Esophageal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05615103 Org: User:
Start: 11/08/22 End: 12/08/23 Due: 12/08/24

Association of Inpatient Blood Pressure Levels With In-hospital Adverse Events(APPLE Study)

Phase: N/A Priority: Normal
NCT ID: NCT04226612 Org: User:
Start: 01/01/00 End: 12/31/30 Due: 12/31/31

Safety and Efficacy of Exercise in Type-B Aortic Dissection

Phase: N/A Priority: Normal
NCT ID: NCT07009067 Org: User:
Start: 05/06/25 End: 12/31/28 Due: 12/31/29

Four-limb Blood Pressures in Infants With High Risk of Congenital Malformation of Aorta

Phase: N/A Priority: Normal
NCT ID: NCT05022836 Org: User:
Start: 01/01/13 End: 06/25/21 Due: 06/25/22

Dose-dense (Biweekly) Carboplatin Plus Paclitaxel With or Without Trastuzumab as Neoadjuvant Treatment for Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02059876 Org: User:
Start: 11/30/13 End: 12/31/14 Due: 12/31/15

MRD Monitoring in Lung Cancer After Resection

Phase: N/A Priority: Normal
NCT ID: NCT04976296 Org: User:
Start: 09/01/21 End: 12/30/27 Due: 12/30/28

Magnesium-L-Threonate Improves Menopausal Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT06959745 Org: User:
Start: 05/15/25 End: 12/30/25 Due: 12/30/26

Ratio of Dietary Calcium to Magnesium on Cardiovascular Risk

Phase: N/A Priority: Normal
NCT ID: NCT04531267 Org: User:
Start: 01/31/21 End: 12/31/21 Due: 12/31/22

Anticoagulation Medicine in Surgical Repair for Total Anomalous Pulmonary Venous Connection

Phase: N/A Priority: Normal
NCT ID: NCT04241380 Org: User:
Start: 02/20/20 End: 03/01/22 Due: 03/01/23

Patient-reported Outcomes in Preoperative Immunochemotherapy/Radiotherapy-treated Esophageal Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT05596890 Org: User:
Start: 11/30/22 End: 09/30/25 Due: 09/30/26

A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA Nephropathy

Phase: N/A Priority: Normal
NCT ID: NCT00426348 Org: User:
Start: 05/31/07 End: 01/31/13 Due: 01/31/14

Nephrotoxicity of Iopamidol Versus Iodixanol in High-Risk Patients

Phase: N/A Priority: Normal
NCT ID: NCT01402219 Org: User:
Start: 11/30/08 End: 05/31/13 Due: 05/31/14

Observational Study for Patients With Dilated Cardiomyopathy

Phase: N/A Priority: Normal
NCT ID: NCT04837612 Org: User:
Start: 01/01/19 End: 01/01/25 Due: 01/01/26

Sutureless Technique and Conventional Repairs for Total Anomalous Pulmonary Venous Connection

Phase: N/A Priority: Normal
NCT ID: NCT04234711 Org: User:
Start: 02/20/20 End: 02/01/22 Due: 02/01/23

Efficacy of Erlotinib for Brain Metastasis of Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00663689 Org: User:
Start: 03/31/08 End: 01/31/12 Due: 01/31/13

A Survey of Factors Affecting an Early or Delayed Diagnosis of IgA Nephropathy

Phase: N/A Priority: Normal
NCT ID: NCT01538433 Org: User:
Start: 02/29/12 End: 12/31/12 Due: 12/31/13

Serum Lipids and Glucose Levels in Relation to CVD Outcomes in Patients With Ischemic Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT03206593 Org: User:
Start: 01/01/16 End: 12/31/19 Due: 12/31/20

Lenvatinib, Tislelizumab Combined With RALOX Regimen HAIC in Advanced Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05954897 Org: User:
Start: 09/01/23 End: 01/01/27 Due: 01/01/28

Temozolomide in Treatment of Patients With Primary Central Nervous System Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02934204 Org: User:
Start: 02/29/16 End: 02/28/19 Due: 02/28/20

Neoadjuvant Treatment With Palbociclib and Exemestane Plus Trastuzumab and Pyrotinib in Estrogen Receptor (ER)-Positive, HER2-positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04858516 Org: User:
Start: 04/30/21 End: 04/30/25 Due: 04/30/26

The Diagnosis and Treatment Pattern of CKD in Patients With Cardiovascular Disease- a National Cross-sectional Study

Phase: N/A Priority: Normal
NCT ID: NCT06143995 Org: User:
Start: 07/01/23 End: 07/31/24 Due: 07/31/25

Implantation of Bone Marrow Cells to Treat Avascular Necrosis of Femoral Head (ANFH)

Phase: N/A Priority: Normal
NCT ID: NCT01613612 Org: User:
Start: 03/31/09 End: 12/31/12 Due: 12/31/13